InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: NY1972 post# 478

Wednesday, 01/27/2021 2:29:57 PM

Wednesday, January 27, 2021 2:29:57 PM

Post# of 932
FT596 targets CD19 and is combined with an anti-CD20 mAb. So both healthy and cancerous cells are targeted. Also, as both are given repeatedly it could lead to either antigen loss or low antigen clones, which can no longer be targeted with either.